COMMODORE CAPITAL LP – Aclaris Therapeutics, Inc. Transaction History
COMMODORE CAPITAL LP portfolio value:
$37.94M
portfolio value
COMMODORE CAPITAL LP quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 4.29M | $15.74 | 2.41M | |
| Q2 2022 | share | Increase | +4.15% | 95.97K shares | -6.25M | $13.96 | 2.41M |
| Q1 2022 | share | Decrease | -13.39% | -357.69K shares | 1.04M | $17.24 | 2.31M |
| Q4 2021 | share | Increase | +22.01% | 482.05K shares | -569K | $14.33 | 2.67M |
| Q3 2021 | share | Increase | +31.23% | 521.30K shares | 10.11M | $18 | 2.19M |
| Q2 2021 | share | Increase | +62.34% | 640.90K shares | 3.39M | $17.56 | 1.66M |
| Q1 2021 | share | Decrease | -23.06% | -308.19K shares | 17.26M | $25.2 | 1.02M |
| Q4 2020 | share | Increase | 0.00% | 1.33M shares | 8.64M | $6.47 | 1.33M |